| Steven W Salzberg, MD | |
|
300 Pinellas St, Clearwater, FL 33756-3804 | |
| (727) 461-8537 | |
| Not Available |
| Full Name | Steven W Salzberg |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 43 Years |
| Location | 300 Pinellas St, Clearwater, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124055967 | NPI | - | NPPES |
| 620505 | Other | FL | BLUE SHIELD OF FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | ME0041348 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Morton Plant Hospital | Clearwater, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bay Area Emergency Physicians Llc | 2668368952 | 6 |
News Archive
Acorda Therapeutics, Inc. today announced that Ron Cohen, M.D., President and Chief Executive Officer, is the recipient of the New York Biotechnology Association "The Cures Start Here" Business Leader of the Year Award. The award is presented for outstanding service to the patient community and to NYBA.
Soluble Systems, LLC and the Skin and Wound Allograft Institute, a wholly owned subsidiary of LifeNet Health, have signed a noteworthy agreement to launch TheraSkin™, a biologically active human skin allograft designed to jumpstart healing in chronic and acute wounds.
Quick-Med Technologies, Inc., a life sciences company that is developing innovative technologies for the healthcare and consumer markets, has recently launched a new website, www.quickmedtech.com, highlighting its innovative patented technologies.
Shih-Hsin (Eddy) Yang, M.D., Ph.D., the ROAR Southeast Cancer Foundation Endowed Chair in the University of Alabama at Birmingham Department of Radiation Oncology, has received a $450,000 grant from Susan G. Komen for the Cure to further investigate HER2-positive breast tumor susceptibility to PARP inhibitors.
› Verified 6 days ago
| Entity Name | Bay Area Emergency Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164459095 PECOS PAC ID: 2668368952 Enrollment ID: O20040224000862 |
News Archive
Acorda Therapeutics, Inc. today announced that Ron Cohen, M.D., President and Chief Executive Officer, is the recipient of the New York Biotechnology Association "The Cures Start Here" Business Leader of the Year Award. The award is presented for outstanding service to the patient community and to NYBA.
Soluble Systems, LLC and the Skin and Wound Allograft Institute, a wholly owned subsidiary of LifeNet Health, have signed a noteworthy agreement to launch TheraSkin™, a biologically active human skin allograft designed to jumpstart healing in chronic and acute wounds.
Quick-Med Technologies, Inc., a life sciences company that is developing innovative technologies for the healthcare and consumer markets, has recently launched a new website, www.quickmedtech.com, highlighting its innovative patented technologies.
Shih-Hsin (Eddy) Yang, M.D., Ph.D., the ROAR Southeast Cancer Foundation Endowed Chair in the University of Alabama at Birmingham Department of Radiation Oncology, has received a $450,000 grant from Susan G. Komen for the Cure to further investigate HER2-positive breast tumor susceptibility to PARP inhibitors.
› Verified 6 days ago
| Entity Name | Pasco County Emergency Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568771707 PECOS PAC ID: 7911196241 Enrollment ID: O20110118000666 |
News Archive
Acorda Therapeutics, Inc. today announced that Ron Cohen, M.D., President and Chief Executive Officer, is the recipient of the New York Biotechnology Association "The Cures Start Here" Business Leader of the Year Award. The award is presented for outstanding service to the patient community and to NYBA.
Soluble Systems, LLC and the Skin and Wound Allograft Institute, a wholly owned subsidiary of LifeNet Health, have signed a noteworthy agreement to launch TheraSkin™, a biologically active human skin allograft designed to jumpstart healing in chronic and acute wounds.
Quick-Med Technologies, Inc., a life sciences company that is developing innovative technologies for the healthcare and consumer markets, has recently launched a new website, www.quickmedtech.com, highlighting its innovative patented technologies.
Shih-Hsin (Eddy) Yang, M.D., Ph.D., the ROAR Southeast Cancer Foundation Endowed Chair in the University of Alabama at Birmingham Department of Radiation Oncology, has received a $450,000 grant from Susan G. Komen for the Cure to further investigate HER2-positive breast tumor susceptibility to PARP inhibitors.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Steven W Salzberg, MD Po Box 850001, Orlando, FL 32885-0001 Ph: (904) 482-1070 | Steven W Salzberg, MD 300 Pinellas St, Clearwater, FL 33756-3804 Ph: (727) 461-8537 |
News Archive
Acorda Therapeutics, Inc. today announced that Ron Cohen, M.D., President and Chief Executive Officer, is the recipient of the New York Biotechnology Association "The Cures Start Here" Business Leader of the Year Award. The award is presented for outstanding service to the patient community and to NYBA.
Soluble Systems, LLC and the Skin and Wound Allograft Institute, a wholly owned subsidiary of LifeNet Health, have signed a noteworthy agreement to launch TheraSkin™, a biologically active human skin allograft designed to jumpstart healing in chronic and acute wounds.
Quick-Med Technologies, Inc., a life sciences company that is developing innovative technologies for the healthcare and consumer markets, has recently launched a new website, www.quickmedtech.com, highlighting its innovative patented technologies.
Shih-Hsin (Eddy) Yang, M.D., Ph.D., the ROAR Southeast Cancer Foundation Endowed Chair in the University of Alabama at Birmingham Department of Radiation Oncology, has received a $450,000 grant from Susan G. Komen for the Cure to further investigate HER2-positive breast tumor susceptibility to PARP inhibitors.
› Verified 6 days ago
Dr. Mark W Stanford, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 Pinellas St, Morton Plant Hospital, Clearwater, FL 33756 Phone: 727-462-7000 Fax: 727-447-7175 | |
Brandi Mcclain Marshall, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 300 Pinellas St, Clearwater, FL 33756 Phone: 727-461-8537 | |
Dr. Wesley Alan Gabbard, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 29296 Us Hwy 19n, Suite 4, Clearwater, FL 33761 Phone: 727-784-8444 Fax: 727-784-8445 | |
William J Beel, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 300 Pinellas St, Clearwater, FL 33756 Phone: 727-461-8537 | |
Ronald Jacobson, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 Pinellas St, Clearwater, FL 33756 Phone: 727-461-8537 | |
Haley Todsen, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 300 Pinellas St, Clearwater, FL 33756 Phone: 727-298-6612 |